Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia

American Journal of Medicine

Volumn 131, Issue 2, 2018, Pages 201.e1-201.e8

  Walsh, Thomas L ^a,b   DiSilvio, Briana E ^a   Hammer, Crystal ^a   Beg, Moeezullah ^a   Vishwanathan, Swati ^a   Speredelozzi, Daniel ^a   Moffa, Matthew A ^a,b   Hu, Kurt ^a   Abdulmassih, Rasha ^a,b   Makadia, Jina T ^a,b   Sandhu, Rikinder ^a,b   Naddour, Mouhib ^a   Chan Tompkins, Noreen H ^a   Trienski, Tamara L ^a   Watson, Courtney ^a   Obringer, Terrence J ^b   Kuzyck, Jim ^a   Bremmer, Derek N ^b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Community acquired pneumonia; Healthcare associated pneumonia; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

AGED; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL READMISSION; HUMAN; INTERVENTION STUDY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PENNSYLVANIA; PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; ALGORITHM; ANTIMICROBIAL STEWARDSHIP; BACTERIAL PNEUMONIA; BLOOD; CLINICAL DECISION MAKING; COMMUNITY ACQUIRED INFECTION; CROSS INFECTION; DRUG ADMINISTRATION; HOSPITALIZATION; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; VERY ELDERLY; VIRUS PNEUMONIA;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; BIOMARKERS; CLINICAL DECISION-MAKING; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PENNSYLVANIA; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROCALCITONIN; RETROSPECTIVE STUDIES;

EID: 85034823016     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2017.08.039     Document Type: Article

References (33)

1. Heffron, R., Pneumonia, with Special Reference to Pneumococcus lobar Pneumonia. 1939, Harvard University Press, Cambridge, Mass.
2. Musher, D.M., Thorner, A.R., Community-acquired pneumonia. N Engl J Med 371 (2014), 1619–1628.
3. Fang, G.D., Fine, M., Orloff, J., et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore) 69 (1990), 307–316.
4. Musher, D.M., Roig, I.L., Cazares, G., et al. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 67 (2013), 11–18.
5. Restrepo, M.I., Mortensen, E.M., Velez, J.A., et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 133 (2008), 610–617.
6. Jain, S., Self, W.H., Wunderink, R.G., et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373 (2015), 415–427.
7. Said, M.A., Johnson, H.L., Nonyane, B.A., et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One, 8(4), 2013 e60273.
8. Lentino, J.R., Lucks, D.A., Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol 25 (1987), 758–762.
9. Ewig, S., Schlochtermeier, M., Goke, N., Niederman, M.S., Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 121 (2002), 1486–1492.
10. Haubitz, S., Mueller, B., Schuetz, P., Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies. Expert Rev Respir Med 7 (2013), 145–157.
11. Christ-Crain, M., Muller, B., Procalcitonin in bacterial infections—hype, hope, more or less?. Swiss Med Wkly 135 (2005), 451–460.
12. Christ-Crain, M., Muller, B., Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 30 (2007), 556–573.
13. Müller, B., White, J.C., Nylén, E.S., et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86 (2001), 396–404.
14. Haeuptle, J., Zaborsky, R., Fiumefreddo, R., et al. Prognostic value of procalcitonin in Legionella pneumonia. Eur J Clin Microbiol Infect Dis 28 (2009), 55–60.
15. Christ-Crain, M., Müller, B., Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 30 (2007), 556–573.
16. Linscheid, P., Seboek, D., Zulewski, H., et al. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 146 (2005), 2699–2708.
17. Self, W.H., Balk, R.A., Grijalva, C.G., et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis 65 (2017), 183–190.
18. Bergin, S.P., Tsalik, E.L., Procalcitonin: the right answer but to which question?. Clin Infect Dis 65 (2017), 191–193.
19. Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004), 600–607.
20. Christ-Crain, M., Stolz, D., Bingisser, R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174 (2006), 84–93.
21. Schuetz, P., Christ-Crain, M., Wolbers, M., et al. Effect of procalcitonin-based guidelines compared to standard guidelines on antibiotic use in lower respiratory tract infections: the randomized-controlled multicenter ProHOSP Trial. JAMA 302 (2009), 1059–1066.
22. Schuetz, P., Briel, M., Christ-Crain, M., et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 55 (2012), 651–662.
23. Schuetz, P., Briel, M., Mueller, B., Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 309 (2013), 717–718.
24. Schuetz, P., Batschwaroff, M., Dusemund, F., et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis 29 (2010), 269–277.
25. Albrich, W.C., Dusemund, F., Bucher, B., et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter post-study survey (ProREAL). Arch Intern Med 172 (2012), 715–722.
26. Walsh, T.L., DiSilvio, B.E., Speredelozzi, D., et al. Evaluation of management of uncomplicated community-acquired pneumonia: a retrospective assessment. Infect Dis Clin Pract 25 (2017), 71–75.
27. bioMérieux, VIDAS B.R.A.H.M.S. Available at: http://www.biomerieux-diagnostics.com/vidas-brahms-pct. (Accessed 2 June 2017)
28. American Thoracic Society, and Infectious Diseases Society of America, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005), 388–416.
29. Mandell, L.A., Wunderink, R.G., Anzueto, A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (2007), S27–S72.
30. Avdic, E., Cushinotto, L.A., Hughes, A.H., et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 54 (2012), 1581–1587.
31. Jenkins, T.C., Stella, S.A., Cervantes, L., et al. Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations. Infection 41 (2013), 135–144.
32. US Department of Health and Human Services, Centers for Disease Control and Prevention, Antibiotic/antimicrobial resistance. Available at: http://www.cdc.gov/drugresistance/. (Accessed 2 June 2017)
33. Spellberg, B., Guidos, R., Gilbert, D., et al. The epidemic of antibiotic-resistance infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46 (2008), 155–164.